Glaucome.net

Le glaucome sur COCNet

COCNet accueil
COCNet - Informations tout public

GLAUCOME

LES
GRANDES ETUDES

Sommaire

MEDLINE

THE OCULAR HYPERTENSION TREATMENT STUDY


Gordon MO, Kass MA. The Ocular Hypertension Treatment Study: design and baseline description of the participants. Arch Ophthalmol. 1999;117(5):573-83. MEDLINE

Keltner JL, Johnson CA, Quigg JM, Cello KE, Kass MA, Gordon MO. Confirmation of visual field abnormalities in the Ocular Hypertension Treatment Study. Ocular Hypertension Treatment Study Group. Arch Ophthalmol. 2000;118(9):1187-94. MEDLINE

Brandt JD, Beiser JA, Kass MA, Gordon MO. Central corneal thickness in the Ocular Hypertension Treatment Study (OHTS). Ophthalmology. 2001;108(10):1779-88. MEDLINE

Feuer WJ, Parrish RK 2nd, Schiffman JC, Anderson DR, Budenz DL, Wells MC, Hess DJ, Kass MA, Gordon MO. The Ocular Hypertension Treatment Study: reproducibility of cup/disk ratio measurements over time at an optic disc reading center. Am J Ophthalmol. 2002;133(1):19-28. MEDLINE

Johnson CA, Keltner JL, Cello KE, Edwards M, Kass MA, Gordon MO, Budenz DL, Gaasterland DE, Werner E. Baseline visual field characteristics in the ocular hypertension treatment study. Ophthalmology. 2002;109(3):432-7. MEDLINE

Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK 2nd, Wilson MR, Kass MA. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):714-20; discussion 829-30. MEDLINE

1: Parrish RK 2nd, Schiffman JC, Feuer WJ, Anderson DR, Budenz DL, Wells-Albornoz MC, Vandenbroucke R, Kass MA, Gordon MO; Ocular Hypertension Treatment Study Group.
Abstract Test-retest reproducibility of optic disk deterioration detected from stereophotographs by masked graders.
Am J Ophthalmol. 2005 Oct;140(4):762-4.
2: Brandt JD, Beiser JA, Gordon MO, Kass MA; Ocular Hypertension Treatment Study (OHTS) Group.
Abstract Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment Study.
Am J Ophthalmol. 2004 Nov;138(5):717-22.
3: Coleman AL, Gordon MO, Beiser JA, Kass MA; Ocular Hypertension Treatment Study.
Abstract Baseline risk factors for the development of primary open-angle glaucoma in the Ocular Hypertension Treatment Study.
Am J Ophthalmol. 2004 Oct;138(4):684-5.
4: Higginbotham EJ, Gordon MO, Beiser JA, Drake MV, Bennett GR, Wilson MR, Kass MA; Ocular Hypertension Treatment Study Group.
Abstract The Ocular Hypertension Treatment Study: topical medication delays or prevents primary open-angle glaucoma in African American individuals.
Arch Ophthalmol. 2004 Jun;122(6):813-20.
5: Zangwill LM, Weinreb RN, Berry CC, Smith AR, Dirkes KA, Coleman AL, Piltz-Seymour JR, Liebmann JM, Cioffi GA, Trick G, Brandt JD, Gordon MO, Kass MA; Confocal Scanning Laser Ophthalmoscopy Ancillary Study to the Ocular Hypertension Treatment Study.
Abstract Racial differences in optic disc topography: baseline results from the confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study.
Arch Ophthalmol. 2004 Jan;122(1):22-8.
6: Keltner JL, Johnson CA, Cello KE, Edwards MA, Bandermann SE, Kass MA, Gordon MO; Ocular Hypertension Treatment Study Group.
Abstract Classification of visual field abnormalities in the ocular hypertension treatment study.
Arch Ophthalmol. 2003 May;121(5):643-50.
7: Lee BL, Wilson MR; Ocular Hypertension Treatment Study (OHTS).
Abstract Ocular Hypertension Treatment Study (OHTS) commentary.
Curr Opin Ophthalmol. 2003 Apr;14(2):74-7. Review.

GLAUCORUM
Le forum glaucome sur COCNet Agora. Pour échanger.
www.glaucorum.fr.fm

RETOUR© MediaMed - 3310.2 page 160106

MediaMed